Kythera (Acquired by Allergan)
Press releases archived for reference only.
30930 Russell Ranch Road
Westlake Village
California
91362
United States
Tel: 818-587-4500
Fax: 818-587-4591
Website: http://www.kythera.com/
About Kythera (Acquired by Allergan)
Oct. 1, 2015 -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that it has successfully completed the acquisition of Kythera Biopharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel prescription products for the medical aesthetics market. Allergan acquired Kythera in an all-cash transaction valued at approximately $2.1 billion.
121 articles about Kythera (Acquired by Allergan)
-
KYTHERA Biopharmaceuticals, Inc. Grants Stock Options Under Inducement Program
3/5/2015
-
KYTHERA Biopharmaceuticals, Inc. Announces 2014 Operating Results
3/3/2015
-
KYTHERA Biopharmaceuticals, Inc. Acquires Worldwide Rights To Clinical Compound And Key Intellectual Property For Potential Novel Treatment Of Hair Loss
2/11/2015
-
KYTHERA Biopharmaceuticals, Inc. To Present At The 2015 Leerink Global Healthcare Conference
2/5/2015
-
KYTHERA Biopharmaceuticals, Inc. Submits Drug Application In Australia For Novel Submental Contouring Injectable Drug ATX-101
2/5/2015
-
KYTHERA Biopharmaceuticals, Inc. Grants Stock Options Under Inducement Program
2/4/2015
-
KYTHERA Biopharmaceuticals, Inc. Announces Date Of FDA Advisory Committee Review Of ATX-101 For The Treatment Of Submental Fullness
1/23/2015
-
KYTHERA Biopharmaceuticals, Inc. Grants Stock Options Under Inducement Program
1/21/2015
-
KYTHERA Biopharmaceuticals, Inc. To Present At The 33rd Annual J.P. Morgan Healthcare Conference
1/6/2015
-
KYTHERA Biopharmaceuticals, Inc. Appoints Hollings C. Renton To Board Of Directors
1/6/2015
-
KYTHERA Biopharmaceuticals, Inc. Grants Stock Options Under Inducement Program
12/15/2014
-
KYTHERA Biopharmaceuticals, Inc. To Present At The Goldman, Sachs & Co. US Emerging / SMID Cap Growth Conference
11/17/2014
-
Kythera Biopharmaceuticals Releases Third Quarter 2014 Operating Results
11/11/2014
-
Kythera Biopharmaceuticals Grants Stock Options Under Inducement Program
11/5/2014
-
Kythera Biopharmaceuticals To Release Third Quarter 2014 Operating Results
11/4/2014
-
Kythera Biopharmaceuticals Grants Stock Options Under Inducement Program
10/22/2014
-
Kythera Biopharmaceuticals Grants Stock Options Under Inducement Program
10/13/2014
-
Kythera Biopharmaceuticals Submits New Drug Submission To Health Canada For ATX-101 As First-In-Class Treatment For The Reduction Of Submental Fat
8/12/2014
-
Kythera Biopharmaceuticals Releases Second Quarter 2014 Operating Results
8/8/2014
-
Kythera Biopharmaceuticals To Release Second Quarter 2014 Operating Results
8/1/2014